Roy S. Herbst, Luis G. Paz-Ares, Martin Reck, Mark M. Awad, Hidetoshi Hayashi, Jianjun Zhang, Andrew Schneider, Hui Zhou, Alexander A. Parent, Masanori Okaniwa, Shun Lu. "Randomized phase 3 study (MarsLight-11) evaluating IBI363 (TAK-928) versus docetaxel in patients (pts) with squamous non-small cell lung cancer (sqNSCLC) after prior chemotherapy (chemo) and immunotherapy (IO).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps8673